$13.80
00.00%
Last update: Aug 26, 2:17 PM
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Swedish Orphan Biovitrum in recent months.
Browse guidance and forecast on all stocks.